2-(6-chloroindazol-2-yl)-1-[(3S,5S,9S,10S,13S,14S,17S)-3-hydroxy-3-methoxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone

C29H39ClN2O3 — CID 163517533

IUPAC2-(6-chloroindazol-2-yl)-1-[(3S,5S,9S,10S,13S,14S,17S)-3-hydroxy-3-methoxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone
SMILESCO[C@@]1(O)CC[C@@]2(C)[C@@H](CCC3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc5ccc(Cl)cc5n4)CC[C@@H]32)C1
InChIInChI=1S/C29H39ClN2O3/c1-27-12-13-29(34,35-3)15-19(27)5-7-21-22-8-9-24(28(22,2)11-10-23(21)27)26(33)17-32-16-18-4-6-20(30)14-25(18)31-32/h4,6,14,16,19,21-24,34H,5,7-13,15,17H2,1-3H3/t19-,21?,22-,23-,24+,27-,28-,29-/m0/s1
InChIKeyDIAFSYZNNUAYGZ-VVANWKJISA-N
MW499.10 g/mol
LogP6.25
Rot. Bonds4

About 2-(6-chloroindazol-2-yl)-1-[(3S,5S,9S,10S,13S,14S,17S)-3-hydroxy-3-methoxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone

2-(6-chloroindazol-2-yl)-1-[(3S,5S,9S,10S,13S,14S,17S)-3-hydroxy-3-methoxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone (PubChem CID 163517533) has the molecular formula C29H39ClN2O3 and a molecular weight of 499.10 g/mol. Its IUPAC name is 2-(6-chloroindazol-2-yl)-1-[(3S,5S,9S,10S,13S,14S,17S)-3-hydroxy-3-methoxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone.

Molecular Properties

Compound Name2-(6-chloroindazol-2-yl)-1-[(3S,5S,9S,10S,13S,14S,17S)-3-hydroxy-3-methoxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone
PubChem CID163517533
Molecular FormulaC29H39ClN2O3
Molecular Weight499.10 g/mol
Exact Mass498.26
IUPAC Name2-(6-chloroindazol-2-yl)-1-[(3S,5S,9S,10S,13S,14S,17S)-3-hydroxy-3-methoxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone
SMILESCO[C@@]1(O)CC[C@@]2(C)[C@@H](CCC3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc5ccc(Cl)cc5n4)CC[C@@H]32)C1
InChIInChI=1S/C29H39ClN2O3/c1-27-12-13-29(34,35-3)15-19(27)5-7-21-22-8-9-24(28(22,2)11-10-23(21)27)26(33)17-32-16-18-4-6-20(30)14-25(18)31-32/h4,6,14,16,19,21-24,34H,5,7-13,15,17H2,1-3H3/t19-,21?,22-,23-,24+,27-,28-,29-/m0/s1
InChIKeyDIAFSYZNNUAYGZ-VVANWKJISA-N
XLogP6.25
TPSA64.35 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms35
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500499.10
LogP ≤ 56.25
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}

Analyze 2-(6-chloroindazol-2-yl)-1-[(3S,5S,9S,10S,13S,14S,17S)-3-hydroxy-3-methoxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(6-chloroindazol-2-yl)-1-[(3S,5S,9S,10S,13S,14S,17S)-3-hydroxy-3-methoxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone?
The IUPAC name of 2-(6-chloroindazol-2-yl)-1-[(3S,5S,9S,10S,13S,14S,17S)-3-hydroxy-3-methoxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone (CID 163517533) is 2-(6-chloroindazol-2-yl)-1-[(3S,5S,9S,10S,13S,14S,17S)-3-hydroxy-3-methoxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone.
What is the SMILES notation for 2-(6-chloroindazol-2-yl)-1-[(3S,5S,9S,10S,13S,14S,17S)-3-hydroxy-3-methoxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone?
The canonical SMILES for 2-(6-chloroindazol-2-yl)-1-[(3S,5S,9S,10S,13S,14S,17S)-3-hydroxy-3-methoxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone is CO[C@@]1(O)CC[C@@]2(C)[C@@H](CCC3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc5ccc(Cl)cc5n4)CC[C@@H]32)C1.
What is the InChIKey of 2-(6-chloroindazol-2-yl)-1-[(3S,5S,9S,10S,13S,14S,17S)-3-hydroxy-3-methoxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone?
The InChIKey is DIAFSYZNNUAYGZ-VVANWKJISA-N. The full InChI is InChI=1S/C29H39ClN2O3/c1-27-12-13-29(34,35-3)15-19(27)5-7-21-22-8-9-24(28(22,2)11-10-23(21)27)26(33)17-32-16-18-4-6-20(30)14-25(18)31-32/h4,6,14,16,19,21-24,34H,5,7-13,15,17H2,1-3H3/t19-,21?,22-,23-,24+,27-,28-,29-/m0/s1.
What are the key properties of 2-(6-chloroindazol-2-yl)-1-[(3S,5S,9S,10S,13S,14S,17S)-3-hydroxy-3-methoxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone?
2-(6-chloroindazol-2-yl)-1-[(3S,5S,9S,10S,13S,14S,17S)-3-hydroxy-3-methoxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone has a molecular weight of 499.10 g/mol, XLogP of 6.25, 4 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(6-chloroindazol-2-yl)-1-[(3S,5S,9S,10S,13S,14S,17S)-3-hydroxy-3-methoxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone is sourced from PubChem (CID 163517533), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).